SCHEMBL9876542

SCHEMBL9876542

NC(=NCCSCc1ccncc1)NCCCc1c[nH]cn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.39
HRH3 Q9Y5N1 2/20 0.39
HRH2 P25021 1/20 0.39
SIGMAR1 Q99720 2/20 0.35
EBP Q15125 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN2A Q99250 1/20 0.34
ALPL P05186 1/20 0.33
ALPI P09923 1/20 0.33
ALPG P10696 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9868525 0.89 SIGMAR1 (0.44) HRH4HRH3HRH2SIGMAR1CYP1A2
SCHEMBL9866042 0.89 SCN5A (0.44) HRH4HRH3HRH2SIGMAR1EBP
SCHEMBL9171834 0.88 HRH4 (0.41) HRH4HRH3HRH2SIGMAR1EBP
SCHEMBL7178167 0.88 HRH4 (0.41) HRH4HRH3HRH2SIGMAR1EBP
SCHEMBL9865263 0.87 LMNA (0.41) HRH4HRH3HRH2HTTSMN1; SMN2
SCHEMBL7180743 0.85 HRH2 (0.37) HRH4HRH3HRH2SIGMAR1EBP
SCHEMBL10371006 0.84 ALDH1A1 (0.41) HRH4HRH3SIGMAR1CYP3A4CYP2D6
SCHEMBL9867274 0.84 MC3R (0.37) HRH4HRH3HRH2SIGMAR1EBP
SCHEMBL7174497 0.82 HRH4 (0.39) HRH4HRH3HRH2SIGMAR1EBP
SCHEMBL10860073 0.82 HRH2 (0.41) HRH4HRH3HRH2SIGMAR1EBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed